Whoa..bad example with the craps analogy. Nobody plays "with the house". IF you're playing craps you are either a Do pass player or a Don't pass player. The house has an odds advantage with each side to make their vig over time. The do and don't players absolutely want the other side to lose, or don't make the pass, so that they can win their bet.
Investors who short a stock are usually held in disdain as are Don't players in Craps. However, depending on the situation, a short investor can make money just as a Don't player can when the craps table is on a 3 rolls and out routine.
I suspect some hedge fund is running up the stock, then shorting to make some money before news arrives. Passes the time and makes some money for the hedgies.
This strategy is getting more risky as time passes since CYDY developed a professional approach with regard to releasing pertinent information that could affect the stock price.
Sometime soon though some very good information will appear and our patience will pay off. That is what happens when a company has good and proveable science behind their product. It has happened countless times before with other drugs and CYDY's time is coming.
Relax and have a root beer or something....